Sheldon Koenig is the President and CEO of Esperion and a Co-Founder of Nuvig Therapeutics. With over two decades of executive experience at Merck and Sanofi, he specializes in global marketing, commercialization, and market access for biotech innovations. People who have worked with him describe him as a "smart" and "savvy" marketer.
He is dedicated to advancing the pharmaceutical industry and expressed a desire for professionals in the field to continue bringing great medicine and research forward. He values a collaborative team approach and engaging with both current and future investors to share compelling company stories.
He has deep expertise in managing all phases of clinical trials (I-V) and possesses extensive knowledge of U. S. reimbursement and global payor strategies.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.